UK Launches First Nationwide Human Biomonitoring Study to Track 'Forever Chemicals'

The UK Health Security Agency (UKHSA) has officially launched the country's first nationwide human biomonitoring study to measure population exposure to per- and polyfluoroalkyl substances (PFAS). The initiative marks a major step in tracking the synthetic compounds, widely known as "forever chemicals," within the British public.[1][2][4]

The study will analyze blood and urine samples collected through the existing Health Survey England. By leveraging an established national health audit, researchers aim to establish a reliable baseline of typical background exposure across the population without requiring a separate, ground-up collection infrastructure.[1]

The screening extends beyond just forever chemicals. Alongside PFAS, the laboratory analysis will track other persistent environmental pollutants, including lead, arsenic, bisphenols, phthalates, and flame retardants. This broad approach aims to capture a comprehensive snapshot of the chemical burden carried by the average citizen.[1]

Initial findings from the biomonitoring program are expected to be published in 2027. These results will provide the first empirical picture of chemical accumulation within the UK, offering policymakers concrete domestic data rather than relying on estimates extrapolated from international studies.[1][4]

The Scope of Forever Chemicals

PFAS represent a massive family of thousands of synthetic organofluorine chemical compounds. Their widespread use began in the late 1930s with the invention of polytetrafluoroethylene, a fluoropolymer coating utilized in everything from non-stick cookware and waterproof clothing to firefighting foams and medical devices. They are highly valued in manufacturing for their exceptional resistance to heat, oil, and water.[5]

However, their defining characteristic—an incredibly strong carbon-fluorine bond—prevents them from breaking down naturally. This durability allows the molecules to accumulate in the environment and the human body over decades, prompting growing international concern over their long-term ecological and biological impacts.[5]

Dr. Edward Wynne-Evans, the UKHSA director of radiation, chemicals, climate, and environmental hazards, acknowledged the growing public unease. "PFAS are an area of significant public interest and we understand the concerns people may have about these chemicals and what they could mean for their health," he stated.[1]

Wynne-Evans noted that critical evidence gaps remain regarding what specific exposure levels mean for individual long-term health. "Our work is focused on helping to address those questions through research, biomonitoring and evidence reviews," he explained, emphasizing the need for localized data.[1]

The agency maintains that any health effects from current background levels are likely to be limited. The strongest global evidence currently points to possible associations with raised cholesterol and potentially lower birth weights, though further work is required to understand the clinical significance of these findings.[1]

Testing Limitations and Health Impacts

Because there is currently no established clinical intervention linked to a particular PFAS blood level, the UKHSA is not recommending routine NHS or private blood testing for the general public. The agency warns that individual testing can sometimes create unnecessary concern without offering a medical solution.[1]

"For that reason, routine testing is not recommended at this time," Wynne-Evans said. He added that while testing could identify whether PFAS were present in an individual, there was insufficient evidence to determine what medical action should follow a specific result.[1]

The biomonitoring study arrives as part of a wider programme of work by the UKHSA, which recently published an evidence review examining research into PFAS and health outcomes. The framework attempts to manage exposure risks while acknowledging the widespread environmental presence of the chemicals.[1]

The independent Committee on Toxicity is also undertaking a detailed review of the available evidence. Meanwhile, the UKHSA is working with international partners, including organizations across Europe, to monitor emerging research and align domestic understanding with global scientific consensus.[1]

Global Context and Contamination

Internationally, PFAS are often found in rainwater, groundwater, wastewater, and soil, with wastewater treatment facilities and landfills showing the highest levels of pollution. Furthermore, crop uptake of PFAS and bioaccumulation into fish, livestock, and wildlife act as significant potential routes of human exposure, complicating efforts to isolate single sources of contamination.[5]

Exposure to certain PFAS compounds, some of which are classified as endocrine disruptors, has been linked in global studies to diseases and health conditions including ulcerative colitis, thyroid disease, decreased immunity, and hypertensive disorders in pregnancy. However, the sheer volume of different PFAS compounds—numbering in the thousands—makes assessing the potential risks of all of them highly challenging due to large data gaps in toxicity.[5]

Due to these severe health and environmental concerns, specific legacy compounds like PFOS and PFOA were listed in the Stockholm Convention on Persistent Organic Pollutants in 2009 and 2019, respectively. Despite these international restrictions, the long environmental lifetimes of the chemicals mean legacy contamination remains a significant issue worldwide, persisting in water tables long after manufacturing ceases.[5]

The UK government's biomonitoring approach aims to build a clearer picture of this legacy contamination domestically. By utilizing state-of-the-art analytical techniques on the Health Survey England blood and urine samples, the UKHSA hopes to separate localized contamination spikes—such as those near industrial sites or airbases—from typical background exposure.[1][5]

Establishing a Domestic Baseline

As the UKHSA processes the first wave of samples through its laboratory infrastructure, the resulting data will likely serve as the empirical foundation for future UK environmental policy. The findings will dictate how aggressively the government pursues further chemical restrictions, providing the hard numbers required to justify sweeping regulatory changes.[1][2]

The 2027 findings will shift the national debate from theoretical risks to measured domestic realities. By establishing a definitive baseline, the study will determine exactly how deeply forever chemicals have integrated into the British population, setting the stage for targeted public health interventions and more robust environmental protections.[1][4]